Your browser doesn't support javascript.
loading
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
Zagouri, Flora; Kastritis, Efstathios; Zomas, Athanasios; Terpos, Evangelos; Katodritou, Eirini; Symeonidis, Argiris; Delimpasi, Sosana; Pouli, Anastasia; Vassilakopoulos, Theodoros P; Michalis, Eurydiki; Giannouli, Stavroula; Kartasis, Zafiris; Christoforidou, Anna; Kokoviadou, Kiriaki; Hatzimichael, Eleftheria; Gika, Dimitra; Megalakaki, Catherine; Papaioannou, Maria; Kyrtsonis, Marie-Christine; Konstantopoulos, Kostas; Dimopoulos, Meletios A.
Afiliação
  • Zagouri F; Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Kastritis E; Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Zomas A; Department of Internal Medicine, Attikon Hospital, Haidari, Greece.
  • Terpos E; Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Katodritou E; Department of Hematology, "Theageneion" Hospital, Thessaloniki, Greece.
  • Symeonidis A; Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece.
  • Delimpasi S; Bone Marrow Transplantation and Lymphoma Unit, "Evangelismos" Hospital, Athens, Greece.
  • Pouli A; Department of Hematology, "Aghios Savvas" Hospital, Athens, Greece.
  • Vassilakopoulos TP; Department of Hematology and BMT Unit, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
  • Michalis E; Department of Hematology, "G. Gennimatas" Hospital, Athens, Greece.
  • Giannouli S; 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Kartasis Z; Chalkis General Hospital, Chalkis, Greece.
  • Christoforidou A; Department of Hematology, Democritus University of Thrace Faculty of Medicine, Alexandroupolis, Greece.
  • Kokoviadou K; Department of Hematology, "Papageorgiou" Hospital, Thessaloniki, Greece.
  • Hatzimichael E; Department of Hematology, University of Ioannina, Ioannina, Greece.
  • Gika D; Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Megalakaki C; Department of Hematology, "Metaxa" Hospital, Piraeus, Greece.
  • Papaioannou M; AHEPA University General Hospital of Thessaloniki, Thessaloniki, Greece.
  • Kyrtsonis MC; First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Konstantopoulos K; Department of Hematology and BMT Unit, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Eur J Haematol ; 99(5): 409-414, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28675766
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipercalcemia / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipercalcemia / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Ano de publicação: 2017 Tipo de documento: Article